Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

Holders of 5% or more of CNTA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Centessa Pharmaceuticals plc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CNTA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Avoro Capital Advisors LLC13G/A7.39%11.4M shares−2.58 ppfrom 9.97%Nov 14, 20253 filingsMay 15, 2026SEC
General Atlantic Cooperatief U.A.13D/A5.00%7.37M shares−1.60 ppfrom 6.60%Jun 11, 20213 filingsNov 28, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

33 Schedule 13D and 13G filings on Centessa Pharmaceuticals plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CNTA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20264:21 PM ETPentwater Capital Management LPand 1 other13G/A0.00%0 shares−5.30 ppfrom 5.30%Below 5%Jun 30, 2026SEC
Aug 14, 20266:47 AM ETIndex Ventures Life VI (Jersey) L.P.and 2 others13G/A0.00%0 shares–Below 5%Jun 30, 2026SEC
Aug 12, 202612:06 PM ETAdage Capital Management, L.P.and 2 others13G/A0.00%0 shares−5.77 ppfrom 5.77%Below 5%Jun 30, 2026SEC
Aug 4, 202611:41 AM ETMedicxi Growth I LPand 9 others13G/A0.00%0 shares–Below 5%Jun 30, 2026SEC
Jul 8, 202610:11 AM ETFMR LLCand 1 other13G/A0.00%1.80K shares−7.50 ppfrom 7.50%Below 5%Jun 30, 2026SEC
Jun 26, 20268:58 AM ETFarallon Capital Management, L.L.C.and 15 others13D/A0.00%0 shares−6.10 ppfrom 6.10%Below 5%Jun 24, 2026SEC
Jun 24, 20266:32 PM ETFarallon Capital Management, L.L.C.and 15 others13D6.10%9.37M sharesNewJun 16, 2026SEC
May 15, 20264:32 PM ETPentwater Capital Management LPand 1 other13G5.30%8.17M sharesNewMar 31, 2026SEC
May 15, 20268:19 AM ETAvoro Capital Advisors LLCand 1 other13G/A7.39%11.4M shares−2.58 ppfrom 9.97%Mar 31, 2026SEC
May 13, 20269:01 AM ETAdage Capital Management, L.P.and 2 others13G/A5.77%8.93M shares−1.71 ppfrom 7.48%Mar 31, 2026SEC
May 6, 202611:06 AM ETFMR LLCand 1 other13G/A7.50%6.78M shares−4.70 ppfrom 12.20%Mar 31, 2026SEC
Feb 17, 20269:04 AM ETAvoro Capital Advisors LLCand 1 other13G/A9.97%14.6M shares+1.91 ppfrom 8.06%Dec 31, 2025SEC
Feb 6, 20261:11 PM ETFMR LLCand 1 other13G/A12.20%11.0M shares+2.30 ppfrom 9.90%Jan 30, 2026SEC
Feb 5, 20261:20 PM ETFMR LLCand 1 other13G/A9.90%8.89M shares+2.90 ppfrom 7.00%Dec 31, 2025SEC
Nov 28, 20255:11 PM ETGeneral Atlantic Cooperatief U.A.and 9 others13D/A5.00%7.37M shares−1.60 ppfrom 6.60%Nov 25, 2025SEC
Nov 17, 20258:53 PM ETGeneral Atlantic Cooperatief U.A.and 9 others13D/A6.60%9.68M shares–Nov 17, 2025SEC
Nov 14, 20259:05 AM ETAvoro Capital Advisors LLCand 1 other13G8.06%10.8M sharesNewSep 30, 2025SEC
Nov 13, 20259:06 AM ETAdage Capital Management, L.P.and 2 others13G/A7.48%10.0M shares+1.19 ppfrom 6.29%Sep 30, 2025SEC
Nov 5, 202511:30 AM ETFMR LLCand 1 other13G7.00%6.28M sharesNewSep 30, 2025SEC
Aug 12, 20259:01 AM ETAdage Capital Management, L.P.and 2 others13G/A6.29%8.40M shares+1.07 ppfrom 5.22%Jun 30, 2025SEC
May 12, 20259:03 AM ETAdage Capital Management, L.P.and 2 others13G5.22%6.95M sharesNewMar 31, 2025SEC
Nov 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Nov 14, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 14, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 9, 2023Janus Henderson Group PLC13G/AOld format–––SEC
Jan 31, 2023Medicxi Growth I LP13G/AOld format–––SEC
Nov 23, 2022EcoR1 Capital, LLC13GOld format–New–SEC
Jun 16, 2022Biotechnology Value Fund L P13GOld format–New–SEC
Feb 14, 2022Index Ventures Life VI (Jersey) L.P.13GOld format–New–SEC
Feb 11, 2022Janus Henderson Group PLC13GOld format–New–SEC
Feb 8, 2022Medicxi Growth I LP13GOld format–New–SEC
Jun 11, 2021General Atlantic Cooperatief U.A.13DOld format–New–SEC

Form 144: proposed insider sales

38 notices from officers, directors and other affiliates planning to sell Centessa Pharmaceuticals plc shares, newest first.

Form 144 notices for CNTA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Dec 26, 20244:02 PM ETWeinhoff Gregory MOfficer10.0K$168.0KDec 26, 202410b5-1UBS Financial Services, IncSEC
Dec 20, 20244:18 PM ETSaha SaurabhOfficer · CEO55.0K$965.3KDec 20, 202410b5-1UBS Financial Services, IncSEC
Dec 17, 20244:02 PM ETBush Tia LOfficer17.8K$320.6KDec 17, 202410b5-1UBS Financial Services, Inc.SEC
Dec 16, 20244:14 PM ETHussain Iqbal JOfficer77.7K$1.29MDec 16, 202410b5-1UBS Financial Services Inc.SEC
Dec 16, 20244:04 PM ETBush Tia LOfficer9.61K$159.3KDec 16, 202410b5-1UBS Financial Services, Inc.SEC
Dec 13, 20244:03 PM ETAnderson Karen M.Officer16.5K$278.7KDec 13, 202410b5-1UBS Financial Services Inc.SEC
Dec 6, 20244:14 PM ETSaha SaurabhOfficer · CEO87.5K$1.62MDec 6, 202410b5-1UBS Financial Services, IncSEC
Nov 25, 20244:07 PM ETWeinhoff Gregory MOfficer10.0K$173.9KNov 25, 202410b5-1UBS Financial Services, IncSEC
Nov 25, 20244:03 PM ETSaha SaurabhOfficer · CEO299$10.5KNov 25, 202410b5-1UBS Financial Services, IncSEC
Nov 22, 20244:03 PM ETSaha SaurabhOfficer · CEO1.67K$30.5KNov 22, 202410b5-1UBS Financial Services, IncSEC
Nov 21, 20244:33 PM ETSaha SaurabhOfficer · CEO3.51K$64.0KNov 21, 202410b5-1UBS Financial Services, IncSEC
Nov 20, 20244:03 PM ETSaha SaurabhOfficer · CEO55.0K$933.4KNov 20, 202410b5-1UBS Financial Services, IncSEC
Nov 13, 20244:18 PM ETSaha SaurabhOfficer · CEO32.0K$585.4KNov 13, 202410b5-1UBS Financial Services, IncSEC
Oct 25, 20244:10 PM ETWeinhoff Gregory MOfficer11.7K$182.8KOct 25, 202410b5-1UBS Financial Services, IncSEC
Oct 23, 20244:07 PM ETSaha SaurabhOfficer · CEO2.59K$40.1KOct 23, 202410b5-1UBS Financial Services, IncSEC
Oct 22, 20244:15 PM ETSaha SaurabhOfficer · CEO30.2K$473.2KOct 22, 202410b5-1UBS Financial Services, IncSEC
Oct 21, 20244:55 PM ETSaha SaurabhOfficer · CEO22.2K$350.9KOct 21, 202410b5-1UBS Financial Services, IncSEC
Sep 25, 20244:01 PM ETWeinhoff Gregory MOfficer16.6K$262.6KSep 25, 202410b5-1UBS Financial Services, IncSEC
Sep 20, 20244:01 PM ETSaha SaurabhOfficer · CEO55.0K$904.8KSep 20, 202410b5-1UBS Financial Services, IncSEC
Sep 10, 20244:06 PM ETSaha SaurabhOfficer · CEO175.0K$2.89MSep 10, 202410b5-1UBS Financial Services, IncSEC
Sep 10, 20244:04 PM ETWeinhoff Gregory MOfficer30.0K$510.0KSep 10, 202410b5-1UBS Financial Services, IncSEC
Sep 9, 20244:07 PM ETWeinhoff Gregory MOfficer25.0K$375.0KSep 9, 202410b5-1UBS Financial Services, IncSEC
Aug 23, 20244:19 PM ETWeinhoff Gregory MOfficer17.8K$218.8KAug 23, 202410b5-1UBS Financial Services, IncSEC
Aug 23, 20244:13 PM ETSaha SaurabhOfficer · CEO46.7K$573.9KAug 23, 202410b5-1UBS Financial Services, IncSEC
Aug 22, 20244:32 PM ETWeinhoff Gregory MOfficer12.2K$149.3KAug 22, 202410b5-1UBS Financial Services, IncSEC

Showing the latest 25. See the CNTA notices from the last 12 months